Efficiency and safety of pemetrexed and cisplatin therapy in the adenocarcinoma and large cell cancer types of advanced non-small cell lung cancer (NSCLC)

Abstract

The report contains results of effecacy and safety data analysis of pemetrexed / cisplatin first-line treatment in patients with advanced / metastatic non-small cell cancer retrieved from the TULUNG patient registry, which monitors the use of expensive NSCLC treatment in Czech centers providing comprehensive care in lung oncology.

Keywords

• pemetrexed
• non-small cell lung cancer
• NSCLC
• first-line treatment